1. Home
  2. GSK

GSK

GSK plc (Each representing two)

Logo GSK plc (Each representing two)

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-18-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Founded: 1715 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 83.5B IPO Year: N/A
Target Price: $46.00 AVG Volume (30 days): 3.6M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: 4.13% Dividend Payout Frequency: Quarterly
EPS: 2.99 EPS Growth: -67.26
52 Week Low/High: $33.33 - $43.84 Next Earning Date: 05-01-2024
Revenue: $38,389,873,418 Revenue Growth: 3.42%
Revenue Growth (this year): 7.24% Revenue Growth (next year): 6.03%

Share on Social Networks: